Clinical Trials

1,978 enrolled

Anatomic Stage II Breast Cancer AJCC v8

NCT07556848 2026-04-30

A Study of 9MW2821 Versus Chemotherapy in Participants With Previously Treated Locally Advanced or Metastatic Triple-Negative Breast Cancer

356 enrolled

Triple Negative Breast Neoplasms

NCT06195709 2026-04-17

ECLECTIC

300 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT06627712 2026-01-30

SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC

318 enrolled

Triple Negative Breast Neoplasms

NCT05909332 2026-01-21

Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03)

764 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07005557 2025-06-05

SENIOR

1,244 enrolled

Breast Neoplasms

NCT06341621 2024-04-10

Rainbow

1,900 enrolled

Breast Neoplasms

NCT04613674 2024-03-27

A Study of Camrelizumab Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC)

441 enrolled

Triple Negative Breast Neoplasms

NCT05999149 2024-02-21

BCTOP-T-N01

424 enrolled

Triple Negative Breast Neoplasms

NCT00004935 2023-04-18

Herceptin Followed by Chemotherapy in Treating Women With Metastatic Breast Cancer That Overexpresses HER2

Phase 3 Terminated

175 enrolled

Phase 3 Active not recruiting

Breast Neoplasms

NCT01646034 2022-10-12

Oligo

74 enrolled

Breast Neoplasms

NCT05346861 2022-04-26

Pyrotinib Rechallenge in Her2-positive Metastatic Breast Cancer Pretreated With Pyrotinib and Trastuzumab

240 enrolled

Breast Neoplasms

NCT02535221 2021-11-29

Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer

234 enrolled

Breast Neoplasms

NCT04736589 2021-02-03

Inetetamab Plus Rapamycin and Chemotherapy for HER2+ Metastatic Breast Cancer With Abnormal Activation of PAM Pathway

270 enrolled

Breast Neoplasms

NCT03055312 2021-01-28

SYSUCC-007

Phase 3 Terminated

36 enrolled

Triple Negative Breast Neoplasms

NCT01104935 2019-10-21

RESPECT

275 enrolled

Breast Neoplasms

NCT01796444 2018-04-05

Z0011-China

Phase 3 Withdrawn

Breast Neoplasms

NCT00382018 2017-11-06

S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With Chemo

624 enrolled 12 charts

Breast Neoplasms

NCT00074152 2017-06-16

CALOR

162 enrolled 17 charts

Breast Neoplasms

NCT00066807 2016-10-28

PERCHE

Phase 3 Terminated

29 enrolled 6 charts

Breast Neoplasms

NCT01250379 2016-02-11

A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Breast Cancer Progressing After First-Line Therapy With Avastin and Chemotherapy (TANIA)

494 enrolled 30 charts

Breast Neoplasms

NCT01204801 2015-09-24

Medifocus301

238 enrolled

Hyperthermia, Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site

NCT00448279 2014-10-24

THOR Study: A Study of Continued Herceptin (Trastuzumab) in Combination With Second Line Chemotherapy in Patients With HER2 Positive Metastatic Breast Cancer.

58 enrolled 11 charts

Breast Neoplasms

NCT00262067 2013-12-13

A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)

1,237 enrolled 14 charts

Breast Neoplasms

NCT01622361 2013-09-30

NEST

290 enrolled

Breast Neoplasms

NCT00639366 2013-08-07

Radiation Therapy to the Head in Preventing Brain Metastases in Women Receiving Trastuzumab and Chemotherapy for Metastatic or Locally Advanced Breast Cancer

390 enrolled

Breast Neoplasms

NCT00403182 2012-06-01

Chemotherapy and Hormone Therapy as First-Line Therapy in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer

Phase 3 Withdrawn

Breast Neoplasms

NCT01180335 2012-03-16

REMAGUS04

303 enrolled